Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents

Fabinyi, David; O'Neill, Evelyn C; Connell, Paul; Clark, Julie

doi:10.1111/j.1442-9071.2011.02575.x

Cited by 31 publications

(30 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In diabetic patients maintained on anticoagulant or antiplatelet therapy who had vitrectomy for vitreous haemorrhage, a postoperative dense VCH was found in 27.6% by Fabinyi et al . and in 11% by Brown and Mahmoud . Of the diabetic patients in our study who had vitrectomy for vitreous haemorrhage, we found a 10% (3/30) rate of postoperative dense VCH.…”

Section: Discussionmentioning

confidence: 43%

Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery

Ryan

Saad

Kirwan

et al. 2012

Clinical Exper Ophthalmology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 43%

Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery

Ryan

Saad

Kirwan

et al. 2012

Clinical Exper Ophthalmology

View full text Add to dashboard Cite

show abstract

“…Therefore, decision regarding maintenance or perioperative discontinuation of anticoagulation therapy should be made before vitrectomy by having appropriate consultations about patients’ systemic conditions. [351352353]…”

Section: Resultsmentioning

confidence: 99%

Diabetic retinopathy clinical practice guidelines: Customized for Iranian population

Rajavi

Safi

Javadi

et al. 2016

J Ophthalmic Vis Res

View full text Add to dashboard Cite

Purpose:To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population.Methods:Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology [Preferred Practice Pattern 2012], and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefits, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9.Results:Agreed recommendations were accepted as the final recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence.Conclusion:This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy.

show abstract

“…This applies to diabetic and non-diabetic patients undergoing vitrectomy 29 30. The risk of haemorrhage might be reduced with smaller incision procedures 31…”

Section: Discussionmentioning

confidence: 99%

Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery

et al. 2014

View full text Add to dashboard Cite

The management of antiplatelet and anticoagulant treatment can be challenging for the ophthalmic surgeon with the risk of impaired surgical view or potentially sight-threatening haemorrhage. With the advent of newer medications and the expanding usage of these drugs, there is a need for up-to-date guidance on the subject. This paper describes the current use of modern antiplatelet and anticoagulant drugs in the UK, and reviews the evidence of such treatments in the context of ophthalmic surgery. A multidisciplinary approach has been used to develop a guideline for the management of antiplatelet and anticoagulation treatment in elective ophthalmic surgery. Specifically, guidance is provided on when and how to stop antiplatelet and anticoagulant treatment and, importantly, when to seek specialist medical advice.

show abstract

Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents

Cited by 31 publications

References 26 publications

Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery

Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery

Diabetic retinopathy clinical practice guidelines: Customized for Iranian population

Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery

Contact Info

Product

Resources

About